These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15173262)

  • 1. New gene discoveries may boost DNA stool testing for colorectal cancer.
    Garber K
    J Natl Cancer Inst; 2004 Jun; 96(11):820-1. PubMed ID: 15173262
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular detection of colorectal neoplasia.
    Ahlquist DA
    Gastroenterology; 2010 Jun; 138(6):2127-39. PubMed ID: 20420950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved fecal DNA test for colorectal cancer screening.
    Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool.
    Villa E; Dugani A; Rebecchi AM; Vignoli A; Grottola A; Buttafoco P; Losi L; Perini M; Trande P; Merighi A; Lerose R; Manenti F
    Gastroenterology; 1996 May; 110(5):1346-53. PubMed ID: 8613038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of cytogenetic tests in colorectal cancer screening.
    Suceveanu AI; Suceveanu A; Voinea F; Mazilu L; Mixici F; Adam T
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):33-8. PubMed ID: 19337631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
    Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
    Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.
    Bosch LJ; Mongera S; Terhaar Sive Droste JS; Oort FA; van Turenhout ST; Penning MT; Louwagie J; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
    Cell Oncol (Dordr); 2012 Aug; 35(4):309-15. PubMed ID: 22821210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.
    Ito Y; Kobayashi S; Taniguchi T; Kainuma O; Hara T; Ochiai T
    Int J Oncol; 2002 Jun; 20(6):1263-8. PubMed ID: 12012008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.
    Zou H; Taylor WR; Harrington JJ; Hussain FT; Cao X; Loprinzi CL; Levine TR; Rex DK; Ahnen D; Knigge KL; Lance P; Jiang X; Smith DI; Ahlquist DA
    Gastroenterology; 2009 Feb; 136(2):459-70. PubMed ID: 19026650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for curable colorectal tumors: an approach for the 21st century.
    Stravitz RT; Sanyal AJ
    Am J Gastroenterol; 1993 Jan; 88(1):148-50. PubMed ID: 8420259
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of the mutated K-Ras biomarker in colorectal carcinoma.
    Doolittle BR; Emanuel J; Tuttle C; Costa J
    Exp Mol Pathol; 2001 Jun; 70(3):289-301. PubMed ID: 11418008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting colorectal cancer in stool with the use of multiple genetic targets.
    Dong SM; Traverso G; Johnson C; Geng L; Favis R; Boynton K; Hibi K; Goodman SN; D'Allessio M; Paty P; Hamilton SR; Sidransky D; Barany F; Levin B; Shuber A; Kinzler KW; Vogelstein B; Jen J
    J Natl Cancer Inst; 2001 Jun; 93(11):858-65. PubMed ID: 11390535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multitarget stool DNA testing for colorectal-cancer screening.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
    N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stool DNA screening for colorectal cancer: opportunities to improve value with next generation tests.
    Kisiel JB; Ahlquist DA
    J Clin Gastroenterol; 2011 Apr; 45(4):301-8. PubMed ID: 20856138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stool-based DNA tests for colorectal cancer: clinical potential and early results.
    Ahlquist DA
    Rev Gastroenterol Disord; 2002; 2 Suppl 1():S20-6. PubMed ID: 12439395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Target Stool DNA Test: Is the Future Here?
    Sweetser S; Ahlquist DA
    Curr Gastroenterol Rep; 2016 Jun; 18(6):30. PubMed ID: 27165404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms.
    Li BS; Wang XY; Xu AG; Ma FL; Ma QY; Li Z; Liu JH; Gan AH; Yu ZJ; Zhang XH; Jiang B
    Clin Colorectal Cancer; 2012 Dec; 11(4):280-90. PubMed ID: 22609129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular stool screening for colorectal cancer. Using DNA markers may be beneficial, but large scale evaluation is needed.
    Ahlquist DA
    BMJ; 2000 Jul; 321(7256):254-5. PubMed ID: 10915110
    [No Abstract]   [Full Text] [Related]  

  • 19. Multitarget Stool DNA for Average Risk Colorectal Cancer Screening: Major Achievements and Future Directions.
    Kisiel JB; Eckmann JD; Limburg PJ
    Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):553-568. PubMed ID: 32439088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation stool DNA testing: expanding the scope.
    Ahlquist DA
    Gastroenterology; 2009 Jun; 136(7):2068-73. PubMed ID: 19379748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.